🚀 VC round data is live in beta, check it out!
Physitrack Valuation Multiples
Discover revenue and EBITDA valuation multiples for Physitrack and similar public comparables like MedApp, EUDA Health, NextPlat, Welby and more.
Physitrack Overview
About Physitrack
Physitrack PLC is a digital healthcare provider, focused on physiotherapy and musculoskeletal care market. The company operates in two business lines namely Lifecare and Wellness. The Lifecare segment is the provision of Lifecare platforms tailored to physiotherapy being made up of the Physitrack PLC, Physiotools OY and Mobilus Digital Rehab AB Physiotools businesses. The Wellness segment relates to the provision of Wellness services including digital platforms to both corporates and individuals. Geographically, the company has its presence in United Kingdom, Europe, North America and Rest of World.
Founded
2012
HQ
Employees
86
Website
Financials (LTM)
EV
$20M
Physitrack Financials
Physitrack reported last 12-month revenue of $16M and negative EBITDA of ($81K).
In the same LTM period, Physitrack generated $16M in gross profit, ($81K) in EBITDA losses, and had net loss of ($5M).
Revenue (LTM)
Physitrack P&L
In the most recent fiscal year, Physitrack reported revenue of $19M and EBITDA of ($2M).
Physitrack expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $16M | XXX | $19M | XXX | XXX | XXX |
| Gross Profit | $16M | XXX | — | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | — | XXX | XXX | XXX |
| EBITDA | ($81K) | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | (1%) | XXX | (13%) | XXX | XXX | XXX |
| EBIT Margin | (29%) | XXX | (12%) | XXX | XXX | XXX |
| Net Profit | ($5M) | XXX | ($8M) | XXX | XXX | XXX |
| Net Margin | (32%) | XXX | (40%) | XXX | XXX | XXX |
| Net Debt | — | — | $5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Physitrack Stock Performance
Physitrack has current market cap of $16M, and enterprise value of $20M.
Market Cap Evolution
Physitrack's stock price is $0.98.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $20M | $16M | 0.3% | XXX | XXX | XXX | $-0.47 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPhysitrack Valuation Multiples
Physitrack trades at 1.2x EV/Revenue multiple, and (247.4x) EV/EBITDA.
EV / Revenue (LTM)
Physitrack Financial Valuation Multiples
As of April 20, 2026, Physitrack has market cap of $16M and EV of $20M.
Equity research analysts estimate Physitrack's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Physitrack has a P/E ratio of (3.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $16M | XXX | $16M | XXX | XXX | XXX |
| EV (current) | $20M | XXX | $20M | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | (247.4x) | XXX | (8.2x) | XXX | XXX | XXX |
| EV/EBIT | (4.2x) | XXX | (8.4x) | XXX | XXX | XXX |
| EV/Gross Profit | 1.2x | XXX | — | XXX | XXX | XXX |
| P/E | (3.1x) | XXX | (2.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (46.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Physitrack Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Physitrack Margins & Growth Rates
Physitrack's revenue in the last 12 month grew by 6%.
Physitrack's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Physitrack's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Physitrack's rule of X is 39% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Physitrack Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | (16%) | XXX | XXX | XXX |
| EBITDA Margin | (1%) | XXX | (13%) | XXX | XXX | XXX |
| EBITDA Growth | (7534%) | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 36% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 112% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Physitrack Public Comps
See public comps and valuation multiples for other Digital Therapeutics and Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Physitrack | XXX | XXX | XXX | XXX | XXX | XXX |
| MedApp | XXX | XXX | XXX | XXX | XXX | XXX |
| EUDA Health | XXX | XXX | XXX | XXX | XXX | XXX |
| NextPlat | XXX | XXX | XXX | XXX | XXX | XXX |
| Welby | XXX | XXX | XXX | XXX | XXX | XXX |
| MRSO | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Physitrack M&A Activity
Physitrack acquired XXX companies to date.
Last acquisition by Physitrack was on XXXXXXXX, XXXXX. Physitrack acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Physitrack
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPhysitrack Investment Activity
Physitrack invested in XXX companies to date.
Physitrack made its latest investment on XXXXXXXX, XXXXX. Physitrack invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Physitrack
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Physitrack
| When was Physitrack founded? | Physitrack was founded in 2012. |
| Where is Physitrack headquartered? | Physitrack is headquartered in United Kingdom. |
| How many employees does Physitrack have? | As of today, Physitrack has over 86 employees. |
| Is Physitrack publicly listed? | Yes, Physitrack is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Physitrack? | Physitrack trades under PTRK ticker. |
| When did Physitrack go public? | Physitrack went public in 2021. |
| Who are competitors of Physitrack? | Physitrack main competitors are MedApp, EUDA Health, NextPlat, Welby. |
| What is the current market cap of Physitrack? | Physitrack's current market cap is $16M. |
| What is the current revenue of Physitrack? | Physitrack's last 12 months revenue is $16M. |
| What is the current revenue growth of Physitrack? | Physitrack revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Physitrack? | Current revenue multiple of Physitrack is 1.2x. |
| Is Physitrack profitable? | No, Physitrack is not profitable. |
| What is the current EBITDA of Physitrack? | Physitrack has negative EBITDA and is not profitable. |
| What is Physitrack's EBITDA margin? | Physitrack's last 12 months EBITDA margin is (1%). |
| What is the current EV/EBITDA multiple of Physitrack? | Current EBITDA multiple of Physitrack is (247.4x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.